Endocrine and metabolic disorders in patients with Gaucher disease type 1: a review.

Małgorzata Kałużna Isabella Trzeciak Masehullah Sadiqi David H Vesole Marek Ruchala

Published in: Orphanet journal of rare diseases (2019)

Conditions relating to hormones and metabolism can be wide-ranging in GD1. Obtained findings were intrinsic to GD either as a deleterious process or a compensatory response and some changes detected may represent co-morbidities. Actively seeking and diagnosing endocrine and metabolic disorders are strongly recommended in GD1 patients to optimize healthcare.

Keyphrases

healthcare
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
mental health
patient reported outcomes
replacement therapy
social media
smoking cessation